Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

baton handoff in track and field race
Biotech

Menarini gets Georgiamune preclinical cancer drug in $1B deal

Maryland-based Georgiamune has licensed a preclinical cancer drug candidate to Stemline Therapeutics, which is owned by Italy's Menarini Group.
Michael Gibney Oct 22, 2026 10:50am
AbbVie

AbbVie posts phase 3 HS win but falls short of expectations

Oct 22, 2026 10:39am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
handshake deal shake hand arrows ok yes

Celltrion picks up another Kaigene antibody for up to $580.5M

Oct 22, 2026 10:22am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
IPO initial public offering Wall Street

Rebranded NodThera plans IPO to fund NLRP3 inhibitor program

Oct 22, 2026 5:27am